Ongoing Living Update of Potential COVID-19 Therapeutics: Summary of Rapid Systematic Reviews. Rapid Review, 8 September 2020
Abstract
More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, we have examined 40 therapeutic options. The Pan American Health Organization (PAHO) is continually monitoring ongoing research on any possible therapeutic options. As evidence emerges, then PAHO will immediately assess and update its position, and particularly as it applies to any special sub-group populations such as children, expectant mothers, those with immune conditions, etc.
Subject
Collections
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Related items
Showing items related by title, author, creator and subject.
-
(PAHOUnited StatesWashington, D.C., 2020)Take home message thus far: • We examined 24 therapeutic options thus far; currently, there is no evidence of any important benefit from any therapeutic option (though remdesivir is revealing promise as one option based ...
-
(PAHOUnited StatesWashington, D.C., 2020)More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, we examined 30 therapeutic options.
-
(PAHOUnited StatesWashington, D.C., 2023)Post COVID-19 condition (PCC), also known as long COVID or post-acute sequelae of SARS-CoV-2 infection (PASC), is the continuation or development of new symptoms in the period after acute infection with SARS-CoV-2. PCC can ...
